More than 29 million Americans live with diabetes, a metabolic disorder that is characterized by insufficient production or inadequate utilization of insulin resulting in abnormal fluctuations in blood glucose. For diabetics, self-monitoring of blood glucose is essential for knowing when to make therapy adjustments. In the United States, the blood glucose monitoring industry has experienced a negative growth trend despite an increasing number of patients with diabetes. Roche is looking for innovative ideas and solutions that may help a traditional blood glucose manufacturer, like Roche, reverse this trend while meeting patient needs.
This is an Ideation Challenge with a guaranteed award for at least one submitted solution.
As manufacturer of the Accu-Chek® brand of blood glucose monitoring systems, Roche Diabetes Care is well known for its high quality and accurate diagnostic products for disease management. In recent years, Roche Diabetes Care, as well as other traditional blood glucose manufacturers, has experienced a negative growth trend in the United States. It is postulated that this market decline is substantially due to reduced reimbursements rates by US Centers for Medicare and Medicaid Services (CMS). Yet Roche remains committed in its goal of offering new blood glucose monitoring solutions to patients with diabetes. To complement its efforts, Roche is looking for innovative ideas and solutions that may help it achieve this goal and reverse the current market trend in the US.
This is an Ideation Challenge, which has the following unique features:
Submissions to this Challenge must be received by 11:59 PM (US Eastern Time) on March 23, 2017.
Late submissions will not be considered.
After the Challenge deadline, the Seeker will complete the review process and make a decision with regards to the Winning Solution(s). All Solvers that submit a proposal will be notified on the status of their submissions; however, no detailed evaluation of individual submissions will be provided.
ABOUT THE SEEKER
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. For more information, please visit http://www.roche.com/.
What is an InnoCentive Ideation™ Challenge?
An InnoCentive Ideation™ Challenge is a broad question formulated to obtain access to new ideas, similar to a global brainstorm for producing a breakthrough idea or market survey which may include ideas for a new product line, a new commercial application for a current product, or even a viral marketing idea to recruit new customers. Ideation™ Challenge submissions are typically about two written pages, and Seekers receive a non-exclusive, perpetual license to use all submissions.
In an Ideation™ Challenge, Solvers may:
Solvers should not reveal any confidential information in their submissions. Often the Ideation™ Challenge will be followed by one or more of the other three Challenge types to further develop the ideas and gain Intellectual Property protection when the concept has been well-defined.